Market Scenario
Cell isolation process involves
separation of one or multiple cell types from the heterogeneous population of
cells for biological, cell-based research, routine clinical diagnosis, and
treatment. Increasing prevalence of cancer, rising government funding for
cell-based research, and technological advancements are major drivers for the
growth of cell isolation market. For instance, in August 2016, GE Healthcare
entered into an agreement with STEMCELL Technologies Inc. to provide T-Cell
reagents for commercial-scale cell therapy production. Furthermore, in July
2017, Bio-Rad Laboratories in collaboration with Illumina, Inc. launched
Single-Cell Sequencing Solution. This solution provides researchers the ability
to investigate the coordinated contribution of individual cells in tissue
function, disease progression, and therapeutic response.
On the other hand, the high cost
of cell isolation systems, complex cell behavior characteristics, and ethical
issues related to embryonic stem cell isolation is likely to hamper the market
growth during the forecast period.
Company Profiles
- Beckman Coulter (Subsidiary
of Danaher Corporation)
- Becton, Dickinson, and
Company
- GE Healthcare (A Fully Owned
Subsidiary of General Electric Company)
- Merck KGaA
- Thermo Fisher Scientific
Inc.
- Miltenyi Biotec
- Pluriselect Life Science
- Stemcell Technologies Inc.
- Terumo Bct (A Subsidiary of
Terumo Corporation)
- Bio-Rad Laboratories, Inc.
Segmentation
The cell isolation market is segmented on the basis of product, cell
type, technique, application, and end-user.
On the basis of the product, the market is classified as consumables and
instruments. The consumables are further classified as reagents, kits, media,
and sera, beads, disposables. The instruments are segmented into centrifuges,
flow cytometers, magnetic-activated cell separation, and filtration system. The
magnetic-activated cell separator system is further classified into manual
magnetic-activated cell separator systems and automated magnetic-activated cell
separator systems.
On the basis of the application, the market is segmented into
biomolecule isolation, cancer research, stem cell research, tissue
regeneration, in vitro diagnostics, and therapeutics.
On the basis of the end-user, the market is segmented as research
laboratories and institutes, hospitals and diagnostic laboratories, cell banks,
biotechnology and biopharmaceutical companies.
On the basis of cell type, the market is segmented into human cells and
animal cells. The human cells are further segmented into differentiated cells
and stem cells.
The cell isolation market on the basis of the technique is segmented as
centrifugation-based cell isolation, surface marker-based cell isolation, and
filtration-based cell isolation.
Regional Market
The American region is expected to dominate the cell isolation market,
owing to the existing well-established healthcare system, increasing prevalence
of cancer cases, increasing government funding in research, and technological
advancements. According to the National Cancer Institute, in 2016, around
1,685,210 new cases of cancer had been diagnosed in the US Furthermore, the
increasing cancer care expenditure in the United States is likely to drive the
market growth. For instance, in 2017, the US Department of Health and Human
Services estimated 147.3 billion USD national expenditures for cancer care.
Europe is anticipated to hold the second position in the cell isolation
market. It is expected that the government support towards research &
development expenditure and rising prevalence chronic diseases such as cancer
is likely to drive the European cell isolation market. According to the
Cancer Research UK, in 2012, 14.1 million cases of cancer were diagnosed all
over the world, and 8.2 million died due to cancer. It also projected that the
number of cancer patients is expected to reach 23.6 million in 2030.
The Asia-Pacific cell isolation market consists of countries namely
China, Japan, Republic of Korea, India, and Australia. The market growth is
mainly driven by rapidly expanding biopharmaceutical industries in the region
and rising government funding in life sciences sector. Moreover, countries like
India and China have established research institutes promoting cell-based
research which contributes to the market growth.
The Middle East & Africa holds the lowest share of the global market
due to low development, lack of technical knowledge, and poor medical
facilities.
Browse Complete 154 Pages Premium Research Report
Enabled with 224 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/cell-isolation-market-6193
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Treatment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment